The main theme of the report is global oncology trends by 2025, including the adoption of new therapies, shifts in treatment modalities, and rising expenditures.
The report highlights the importance of investments in screening, early diagnosis, and access to cancer treatment. The study profiles the current state of oncology research and development, including key mechanisms, targets, and cancer types, as well as new areas of research. The report also examines disparities in patient access to new drugs and the use of new mechanisms in treating different cancer types. Treatment costs are increasing due to longer treatment durations and the use of more advanced therapies, which strain healthcare budgets despite the role of biosimilars in reducing expenses.